Literature DB >> 30033757

Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Didier Jutras-Aswad1,2, Bernard Le Foll3,4, Julie Bruneau1,5, T Cameron Wild6, Evan Wood7,8, Benedikt Fischer4,9.   

Abstract

Keywords:  Canada; cannabis; cannabis use disorder; legalization; treatment

Mesh:

Year:  2018        PMID: 30033757      PMCID: PMC6405802          DOI: 10.1177/0706743718790955

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  47 in total

1.  Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers.

Authors:  Margaret Haney; Ziva D Cooper; Gillinder Bedi; Evan Herrmann; Sandra D Comer; Stephanie Collins Reed; Richard W Foltin; Frances R Levin
Journal:  Addict Biol       Date:  2018-04-16       Impact factor: 4.280

2.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

3.  US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013.

Authors:  Deborah S Hasin; Aaron L Sarvet; Magdalena Cerdá; Katherine M Keyes; Malka Stohl; Sandro Galea; Melanie M Wall
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

Review 4.  Development and consequences of cannabis dependence.

Authors:  Alan J Budney; Brent A Moore
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

5.  Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013.

Authors:  Richard A Grucza; Arpana Agrawal; Melissa J Krauss; Jahnavi Bongu; Andrew D Plunk; Patricia A Cavazos-Rehg; Laura J Bierut
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-04-07       Impact factor: 8.829

Review 6.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

7.  A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

Authors:  Kenneth M Carpenter; David McDowell; Daniel J Brooks; Wendy Y Cheng; Frances R Levin
Journal:  Am J Addict       Date:  2009 Jan-Feb

8.  Prevalence, correlates and comorbidity of DSM-IV Cannabis Use and Cannabis Use Disorders in Australia.

Authors:  Maree Teesson; Tim Slade; Wendy Swift; Katherine Mills; Sonja Memedovic; Louise Mewton; Rachel Grove; Nicola Newton; Wayne Hall
Journal:  Aust N Z J Psychiatry       Date:  2012-09-14       Impact factor: 5.744

9.  Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands.

Authors:  Tom P Freeman; Peggy van der Pol; Wil Kuijpers; Jeroen Wisselink; Ravi K Das; Sander Rigter; Margriet van Laar; Paul Griffiths; Wendy Swift; Raymond Niesink; Michael T Lynskey
Journal:  Psychol Med       Date:  2018-01-31       Impact factor: 7.723

10.  Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis.

Authors:  Aaron L Sarvet; Melanie M Wall; David S Fink; Emily Greene; Aline Le; Anne E Boustead; Rosalie Liccardo Pacula; Katherine M Keyes; Magdalena Cerdá; Sandro Galea; Deborah S Hasin
Journal:  Addiction       Date:  2018-02-22       Impact factor: 6.526

View more
  2 in total

1.  Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.

Authors:  Benedikt Fischer; Monica Malta; Guilherme Messas; Marcelo Ribeiro
Journal:  Braz J Psychiatry       Date:  2019 Nov-Dec       Impact factor: 2.697

2.  The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.

Authors:  Benedikt Fischer; Dimitri Daldegan-Bueno; Ross Bell; Joseph M Boden; Chris Bullen; Michael Farrell; Wayne Hall; David Newcombe
Journal:  Public Health Pract (Oxf)       Date:  2020-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.